Results 91 to 100 of about 6,393 (198)

Therapy of Venezuelan patients with severe mucocutaneous or early lesions of diffuse cutaneous leishmaniasis with a vaccine containing pasteurized Leishmania promastigotes and bacillus Calmette-Guerin: preliminary report

open access: yesMemorias do Instituto Oswaldo Cruz, 2004
Severe mucocutaneous (MCL) and diffuse (DCL) forms of American cutaneous leishmaniasis (ACL) are infrequent in Venezuela. Chemotherapy produces only transitory remission in DCL, and occasional treatment failures are observed in MCL.
Jacinto Convit   +6 more
doaj   +1 more source

Dermatologic and otorhinolaryngologic manifestations in leishmaniasis

open access: yesInternational Archives of Otorhinolaryngology, 2011
Introduction: Leishmaniasis is an extremely important parasitic disease as regards epidemiology, and, in such a disease, man is an occasional host to the Leishmania protozoon.
Mota, Luiz Alberto Alves   +1 more
doaj  

The molecular epidemiology and phylogeography of Trypanosoma cruzi and parallel research on Leishmania: looking back and to the future. [PDF]

open access: yes, 2009
Trypanosoma cruzi is the protozoan agent of Chagas disease, and the most important parasitic disease in Latin America. Protozoa of the genus Leishmania are global agents of visceral and cutaneous leishmaniasis, fatal and disfiguring diseases.
Fitpatrick, S.   +15 more
core   +1 more source

Leishmaniasis in humans and small animals: Updates and insights through a one health

open access: yesLetters in Animal Biology
Leishmaniasis is neglected infectious disease caused by a type of microscopic parasite called Leishmania spp. This disease can affect both humans and animals, as well as sandflies.
Amirhossein Badkoubi   +6 more
doaj   +1 more source

Leishmaniasis: An Arabic Middle Eastern Glimpse [PDF]

open access: yesAfro-Egyptian Journal of Infectious and Endemic Diseases
Leishmaniasis is a neglected, chronic vector-borne disease caused by an obligatory intracellular protozoan. Although the number of cases is not rising worldwide, it is geographically widespread. It is endemic in most Arabic countries. Human leishmaniasis
John Nazeer, Ayman Ashkar
doaj   +1 more source

Clinical and therapeutic characteristics of 206 patients with mucocutaneous leishmaniasis. INI FIOCRUZ, 2014.

open access: yes, 2014
n-valid numbers, Md - median, IQR - interquartile range.Clinical and therapeutic characteristics of 206 patients with mucocutaneous leishmaniasis. INI FIOCRUZ, 2014.
Cláudia Maria Valete-Rosalino (3173487)   +10 more
core   +1 more source

Leishmania major: genetic heterogeneity of Iranian isolates by single-strand conformation polymorphism and sequence analysis of ribosomal DNA internal transcribed spacer.

open access: yes, 2006
Protozoan parasites of Leishmania major are the causative agents of cutaneous leishmaniasis in different parts of Iran. We applied PCR-based methods to analyze L.
Mauricio, Isabel L   +6 more
core   +1 more source

Stigma associated with cutaneous and mucocutaneous leishmaniasis: A systematic review. [PDF]

open access: yesPLoS Negl Trop Dis, 2023
Nuwangi H   +5 more
europepmc   +1 more source

Leishmaniose tegumentar americana na Ilha Grande, Rio de Janeiro: IV. reservatórios doméstios

open access: yesRevista da Sociedade Brasileira de Medicina Tropical, 1981
Durante um surto de Leishmaniose Tegumemar Americana (LTA) na Praia Vermelha, Ilha Grande, município de Angra dos Reis, RJ, durante o ano de 1976, os autores examinaram 64 animais domésticos sendo 38 cães e 28 gatos. Nos 38 cães examinados, constatou-se,
Nelson A. de Araújo Filho   +2 more
doaj  

Use of itraconazole in the treatment of mucocutaneous leishmaniasis: A pilot study

open access: yes, 2000
Objectives: Mucocutaneous leishmaniasis is widely distributed in Brazil, with Leishmania (Viannia) braziliensis being the major etiologic agent. The currently recommended therapy is limited by its parenteral use, high toxicity, and variable efficacy.
Nicodemo, Antônio C.   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy